Mark Alan Goldberg Idera Pharmaceuticals, Inc. (IDRA) insider trading activity

Mark Alan Goldberg is of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 48,610 shares of IDRA, which is worth approximately $146,316. The most recent transaction as insider was on Apr 01, 2021, when has been sold 10,511 shares (Common Stock) at a price of $1.32 per share, resulting in proceeds of $13,875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.6K

0% 3M change

0% 12M change

Total Value Held $146,316

Mark Alan Goldberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2021	BUY Grant, award, or other acquisition	$13,875 $1.32 p/Share	10,511 Added 17.78%	48,610 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	$13,877 $4.02 p/Share	3,452 Added 8.31%	38,099 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	$13,874 $2.25 p/Share	6,166 Added 15.11%	34,647 Common Stock

Also insider at

IMGN

ImmunoGen, Inc. Healthcare

Director

BPMC

Blueprint Medicines Corp Healthcare

GLYC

GLYCOMIMETICS INC Healthcare

MAG